A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Nintedanib
Related studies linked through entity extraction aliases.
Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
- Status
- COMPLETED
- Phase
- N/A
Efficacy & Safety of Nintedanib in Patients With Progressive Fibrosing Coal Mine Dust-Induced Interstitial Lung Disease
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
- Status
- RECRUITING
- Phase
- PHASE2
Drug-drug Interaction Study with GLPG4716 and Nintedanib and Pirfenidone in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia
- Status
- UNKNOWN
- Phase
- PHASE4
An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
- Status
- COMPLETED
- Phase
- N/A
The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19
- Status
- COMPLETED
- Phase
- PHASE4
Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan
- Status
- COMPLETED
- Phase
- N/A
Safety and Effectiveness of Nintedanib in Korean Patients
- Status
- COMPLETED
- Phase
- N/A
Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)
- Status
- COMPLETED
- Phase
- PHASE3
A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking
- Status
- COMPLETED
- Phase
- N/A
A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
- Status
- COMPLETED
- Phase
- PHASE3